Aurora kinase and p53 family members expression studied in human BC cells showed, that in tumors with low p53 expression, the presence of either high AURKA or AURKB expression levels predicted an increased risk for relapse and mortality and high baseline AURKA expression predicted for inferior OS (Burgess et al. 2022). This evidence concerns the gene AURKB and breast cancer.